Effect of drug interactions between carbapenems and valproate on serum valproate concentration: a systematic review and meta-analysis

References

• Anthony G, Marson GJS. Valproate. In: Shorvon S, Perucca E, Engel J, eds. The treatment of epilepsy. fourth ed. John Wiley & Sons; 2015. p. 652–666.
   Google Scholar
• Perucca E. Introduction to the choice of antiepileptic drugs. In: Shorvon S, Perucca, Engel, eds. The treatment of epilepsy, Fourth ed. John Wiley & Sons, Ltd.; 2015. p. 365–375.
   Google Scholar
• Patsalos PN, Berry DJ, Bourgeois BFD, et al. Antiepileptic drugs–best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE commission on therapeutic strategies. Epilepsia. 2008;49:1239–1276.
   PubMed Web of Science ®Google Scholar
• Miller AD, Ball AM, Bookstaver PB, et al. Epileptogenic potential of carbapenem agents: mechanism of action, seizure rates, and clinical considerations. Pharmacotherapy. 2011;31:408–423.
   PubMed Web of Science ®Google Scholar
• Mancl EE, Gidal BE. The effect of carbapenem antibiotics on plasma concentrations of valproic acid. Ann Pharmacother. 2009;43:2082–2087.
   PubMed Web of Science ®Google Scholar
• Deshayes S, Coquerel A, Verdon R. Neurological adverse effects attributable to beta-lactam antibiotics: a literature review. Drug Saf. 2017;40:1171–1198.
   PubMed Web of Science ®Google Scholar
• Mori H, Takahashi K, Mizutani T. Interaction between valproic acid and carbapenem antibiotics. Drug Metab Rev. 2007;39:647–657.
   PubMed Web of Science ®Google Scholar
• Tobin JK, Golightly LK, Kick SD, et al. Valproic acid-carbapenem interaction: report of six cases and a review of the literature. Drug Metabol Drug Interact. 2009;24:153–182.
   PubMedGoogle Scholar
• Carnovale C, Pozzi M, Mazhar F, et al. Interactions between antiepileptic and antibiotic drugs: a systematic review and meta-analysis with dosing implications. Clin Pharmacokinet. 2018;58:875–886.
   Web of Science ®Google Scholar
• Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non randomised studies in meta-analyses. (Accessed 2020 Aug). Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
   Google Scholar
• National Heart L. Blood institute quality assessment tool for case series. [cited 2019 Jun 1]. Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.
   Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188.
   PubMed Web of Science ®Google Scholar
• Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.
   PubMedGoogle Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
   PubMed Web of Science ®Google Scholar
• Bede P, Lawlor D, Solanki D, et al. Carbapenems and valproate: A consumptive relationship. Epilepsia Open. 2016;2:107–111.
   PubMedGoogle Scholar
• Haroutiunian S, Ratz Y, Rabinovich B, et al. Valproic acid plasma concentration decreases in a dose-independent manner following administration of meropenem: A retrospective study. J Clin Pharmacol. 2009;49:1363–1369.
   PubMed Web of Science ®Google Scholar
• Huang CR, Lin CH, Hsiao SC, et al. Drug interaction between valproic acid and carbapenems in patients with epileptic seizures. Kaohsiung J Med Sci. 2017;33:130–136.
   PubMed Web of Science ®Google Scholar
• Lee MC, Sun YH, Lee CH, et al. Interaction between valproic acid and carbapenems: case series and literature review. Tzu Chi Med J. 2012;24:80–84.
   Google Scholar
• Mink S, Muroi C, Seule M, et al. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg. 2011;113:644–648.
   PubMed Web of Science ®Google Scholar
• Miranda Herrero MC, Alcaraz Romero AJ, Escudero Vilaplana V, et al. Pharmacological interaction between valproic acid and carbapenem: what about levels in pediatrics? Eur J Paediatr Neurol. 2015;19:155–161.
   PubMed Web of Science ®Google Scholar
• Park MK, Lim KS, Kim TE, et al. Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: overview of 6 cases. Ther Drug Monit. 2012;34:599–603.
   PubMed Web of Science ®Google Scholar
• Spriet I, Goyens J, Meersseman W, et al. Interaction between valproate and meropenem: A retrospective study. Ann Pharmacother. 2007;41:1130–1136.
   PubMed Web of Science ®Google Scholar
• Vélez Díaz-Pallarés M, Delgado Silveira E, Alvarez Díaz AM, et al. [Analysis of the valproic acid-meropenem interaction in hospitalised patients]. Neurologia. 2012;27:34–38.
   PubMed Web of Science ®Google Scholar
• Wen ZP, Fan SS, Du C, et al. Drug–drug interaction between valproic acid and meropenem: a retrospective analysis of electronic medical records from neurosurgery inpatients. J Clin Pharm Ther. 2017;42:221–227.
   PubMed Web of Science ®Google Scholar
• Wu CC, Pai TY, Hsiao FY, et al. The effect of different carbapenem antibiotics (ertapenem, imipenem/ cilastatin,and meropenem) on serum valproic acid concentrations. Ther Drug Monit. 2016;38:587–592.
   PubMed Web of Science ®Google Scholar
• Cannon JP, Lee TA, Clark NM, et al. The risk of seizures among the carbapenems: a meta-analysis. J Antimicrob Chemother. 2014;69:2043–2055.
   PubMed Web of Science ®Google Scholar
• Dreucean D, Beres K, McNierney-Moore A, et al. Use of meropenem to treat valproic acid overdose. Am J Emerg Med. 2019;37:2120.e5-2120.e7.
   PubMed Web of Science ®Google Scholar
• Khobrani MA, Dudley SW, Huckleberry YC, et al. Intentional use of carbapenem antibiotics for valproic acid toxicity: A case report. J Clin Pharm Ther. 2018;43:723–725.
   PubMed Web of Science ®Google Scholar
• Suzuki E, Koyama K, Nakai D, et al. Observation of clinically relevant drug interaction in chimeric mice with humanized livers: the case of valproic acid and carbapenem antibiotics. Eur J Drug Metab Pharmacokinet. 2017;42:965–972.
   PubMed Web of Science ®Google Scholar
• Suzuki E, Nakai D, Ikenaga H, et al. In vivo inhibition of acylpeptide hydrolase by carbapenem antibiotics causes the decrease of plasma concentration of valproic acid in dogs. Xenobiotica. 2016;46:126–131.
   PubMed Web of Science ®Google Scholar
• Muzyk AJ, Candeloro CL, Christopher EJ. Drug interaction between carbapenems and extended-release divalproex sodium in a patient with schizoaffective disorder. Gen Hosp Psychiatry. 2010;32:560.e1-560.e3.
   Google Scholar
• Paulzen M, Eap CB, Gründer G, et al. Pharmacokinetic interaction between valproic acid, meropenem, and risperidone. J Clin Psychopharmacol. 2016;36:90–92.
   PubMed Web of Science ®Google Scholar
• Lunde JL, Nelson RE, Storandt HF. Acute seizures in a patient receiving divalproex sodium after starting ertapenem therapy. Pharmacotherapy. 2007;27:1202–1205.
   PubMed Web of Science ®Google Scholar
• Coves-Orts FJ, Borrás-Blasco J, Navarro-Ruiz A, et al. Acute seizures due to a probable interaction between valproic acid and meropenem. Ann Pharmacother. 2005;39:533–537.
   PubMed Web of Science ®Google Scholar
• Fudio S, Carcas A, Piñana E, et al. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem. J Clin Pharm Ther. 2006;31:393–396.
   PubMed Web of Science ®Google Scholar